Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Infinity Pharmaceuti (INFI)

Infinity Pharmaceuti (INFI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 293,398
  • Shares Outstanding, K 88,640
  • Annual Sales, $ 1,720 K
  • Annual Income, $ -40,490 K
  • 60-Month Beta 2.29
  • Price/Sales 178.41
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade INFI with:

Options Overview

Details
  • Implied Volatility 109.58%
  • Historical Volatility 87.39%
  • IV Percentile 8%
  • IV Rank 8.79%
  • IV High 700.94% on 11/04/20
  • IV Low 52.61% on 07/02/20
  • Put/Call Vol Ratio 0.38
  • Today's Volume 1,068
  • Volume Avg (30-Day) 1,350
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 23,706
  • Open Int (30-Day) 17,168

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.14
  • Number of Estimates 4
  • High Estimate -0.13
  • Low Estimate -0.14
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +26.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.75 +13.45%
on 03/17/21
3.78 -17.46%
on 03/18/21
unch (unch)
since 03/12/21
3-Month
2.33 +33.91%
on 03/05/21
5.98 -47.83%
on 02/11/21
+0.18 (+6.12%)
since 01/14/21
52-Week
0.78 +300.00%
on 07/14/20
5.98 -47.83%
on 02/11/21
+2.20 (+239.13%)
since 04/14/20

Most Recent Stories

More News
FibroGen (FGEN) DMD Drug Pamrevlumab Gets FDA's Fast Track Tag

The FDA bestows a Fast Track designation to FibroGen's (FGEN) anti-CTGF antibody, pamrevlumab, to treat patients with Duchenne muscular dystrophy. Shares up.

ZTS : 163.08 (-0.24%)
INFI : 3.12 (+2.63%)
FGEN : 19.26 (-2.38%)
CTLT : 109.91 (+0.80%)
Thinking about buying stock in electroCore, Hall of Fame Resort & Entertainment, Dolphin Entertainment, Alithya Group, or Infinity Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ECOR, HOFV, DLPN, ALYA, and INFI.

ALYA : 2.29 (+0.88%)
DLPN : 9.81 (-1.41%)
ECOR : 1.8200 (-1.09%)
HOFV : 3.62 (+1.40%)
INFI : 3.12 (+2.63%)
Thinking about buying stock in SuperCom, Clovis Oncology, Mogo Inc, Evolus, or Infinity Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SPCB, CLVS, MOGO, EOLS, and INFI.

MOGO : 8.70 (-9.47%)
CLVS : 6.25 (+1.79%)
EOLS : 11.72 (+0.51%)
INFI : 3.12 (+2.63%)
SPCB : 1.4400 (-3.36%)
Is the Options Market Predicting a Spike in Infinity (INFI) Stock?

Investors need to pay close attention to Infinity (INFI) stock based on the movements in the options market lately.

INFI : 3.12 (+2.63%)
Thinking about buying stock in Can Fite Biopharma, Aytu Bioscience, Hall of Fame Resort & Entertainment, Brickell Biotech, or Infinity Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CANF, AYTU, HOFV, BBI, and INFI.

CANF : 2.27 (-0.87%)
BBI : 0.8800 (-4.07%)
HOFV : 3.62 (+1.40%)
INFI : 3.12 (+2.63%)
Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Tops Revenue Estimates

Infinity (INFI) delivered earnings and revenue surprises of -6.25% and 11.80%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

INFI : 3.12 (+2.63%)
Infinity: Q4 Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Infinity Pharmaceuticals Inc. (INFI) on Tuesday reported a loss of $10.6 million in its fourth quarter.

INFI : 3.12 (+2.63%)
Infinity: Q4 Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Infinity Pharmaceuticals Inc. (INFI) on Tuesday reported a loss of $10.6 million in its fourth quarter.

INFI : 3.12 (+2.63%)
Infinity Pharmaceuticals Reports Full Year 2020 Financial Results and Provides Update on Eganelisib Development

--- MARIO-3 initial data at SABCS demonstrate tumor reduction in 100% of patients and an ORR of 69.2%, irrespective of PD-L1 status, in 1L TNBC patients; updates in 1H '21 and 2H '21 -

INFI : 3.12 (+2.63%)
Infinity Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 16, 2021 / Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 16, 2021...

INFI : 3.12 (+2.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Infinity Pharmaceuticals, Inc. is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions.

See More

Key Turning Points

3rd Resistance Point 3.50
2nd Resistance Point 3.38
1st Resistance Point 3.25
Last Price 3.12
1st Support Level 3.00
2nd Support Level 2.88
3rd Support Level 2.75

See More

52-Week High 5.98
Fibonacci 61.8% 3.99
Fibonacci 50% 3.38
Last Price 3.12
Fibonacci 38.2% 2.77
52-Week Low 0.78

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar